OncoMed Pharmaceuticals - 48 Year Dividend Yield History | OMED
Historical dividend payout and yield for OncoMed Pharmaceuticals (OMED) since 1971. The current TTM dividend payout for OncoMed Pharmaceuticals (OMED) as of February 15, 2019 is $0.00. The current dividend yield for OncoMed Pharmaceuticals as of February 15, 2019 is 0.00%.
||Medical - Biomedical and Genetics
OncoMed Pharmaceuticals, Inc. is a biopharmaceutical company which focuses on the discovering and developing monoclonal antibody therapeutics for cancer stem cells. It utilizes its technologies to identify, isolate and evaluate CSCs, validate multiple potential targets and pathways critical to CSC self-renewal and differentiation and develop antibody and other protein-based therapeutics. The company serves the healthcare industry and cancer therapy patients. OncoMed Pharmaceuticals, Inc. is based in Redwood City, United States.